# LQ3 Pharmaceuticals, Inc. — Form D/A

LQ3 Pharmaceuticals, Inc. of MORRISVILLE, NC, a company, filed a Form D amendment with the SEC on 2014-12-17. The offering totals $10.0M, of which $2.4M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2014-12-17
- Form: D/A
- Accession: 0001614268-14-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $2.4M
- Remaining: $7.6M
- Investors: 4
- Date of first sale: 2014-07-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-221630

## Issuer

- Name: LQ3 Pharmaceuticals, Inc.
- CIK: 0001614268
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 419 DAVIS DRIVE, MORRISVILLE, NC, 27560
- Phone: 919.328.4377

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Stephen Bloch | Director | Parsippany, NJ |
| KYLE CHENET | Director | Durham, NC |
| Neal Fowler | Director | DURHAM, NC |
| Seth Rudnick | Director | DURHAM, NC |
| Tim Albury | Executive Officer | MORRISVILLE, NC |
| KYLE CHENET | Executive Officer | Durham, NC |
| Shawn Glidden | Executive Officer | MORRISVILLE, NC |
| KYLE CHENET | Promoter | Durham, NC |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-07-23](https://search.stillhousedata.com/formd/0001614268-14-000001) | D | $10.0M | $2.0M |

## More

- [CIK 1614268 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1614268&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001614268-14-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.